bitBiome, Inc. – Trademark Portfolio
Entity Type: 03
bitBiome, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 5 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include B, I, BIT-MAP, and BITBIOME.
1-22-3, Nishi-waseda, Shinjuku-ku
Tokyo 1690051
Showing of trademarks Trademarks
Trademark Classifications
bitBiome, Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does bitBiome, Inc. have?
bitBiome, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does bitBiome, Inc. file in?
bitBiome, Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 35 (Advertising & Business), Class 1 (Chemicals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are bitBiome, Inc.'s most well-known trademarks?
bitBiome, Inc.'s registered trademark portfolio includes well-known marks such as B, I, BIT-MAP, and BITBIOME. These are among 5 currently registered trademarks in the portfolio.
What is bitBiome, Inc.'s trademark registration success rate?
bitBiome, Inc. has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.